Health
Lower Radiotherapy Dose Shows Promise for Treating HPV-Related Oropharyngeal Cancer – Cancer Network
Given the current study findings, investigators suggested intratherapy personalization of chemoradiotherapy may possibly facilitate marked de-escalation of radiotherapy…
De-escalation of radiotherapy to 30 Gy on the basis of intratreatment hypoxia imaging among patients with head and neck cancers related to human papillomavirus (HPV) infection is feasible, safe, and associated with minimal toxicity, according to a pilot study published in the Journal of the National Cancer Institute.1
Patients with HPV-related oropharyngeal cancers typically have good outcomes but experience clinically significant toxicities when treated with standard chemoradiotherapy at a dose…
-
Noosa News23 hours agoTayla Harris stars as Melbourne defeats Essendon by 14 points
-
General24 hours agoa pivotal moment in Liberal power struggle
-
General11 hours agoAustralia welcomes Gaza peace progress, hostage release
-
Business13 hours agoBell Potter names the best ASX shares to buy in October